Literature DB >> 28744498

Ex vivo 1H MR spectroscopy and histology after experimental chronic spinal cord compression.

Stephan Duetzmann1, Ulrich Pilatus2, Volker Seifert1, Gerhard Marquardt1, Matthias Setzer1.   

Abstract

BACKGROUND: Proton magnetic resonance imaging (MRS) is used increasingly to image the spinal cord in compressive cervical myelopathy (CSM). However, detailed analyses of the underlying histomorphological changes leading to MRS alterations are still lacking. The aim of our study was to correlate neuroimaging and neuropathologic alterations in a rabbit myelopathy model.
METHODS: Chronic spinal cord compression was induced in a rabbit model (n=16) allowing for a gradual 270° compression of the spinal cord. Spinal cord compression core areas were divided into two samples for (A) 1H MRS and (B) histopathological analyses. Postoperatively the animals underwent a neurological examination twice a day and outcome was categorized in pattern of injury and amount of recovery.
RESULTS: Three groups were observed and categorized: (I) animals with severe deficits and no or minimal recovery; (II) animals with severe deficits and complete or almost complete recovery; (III) animals with mild to moderate deficits and a complete recovery. Significant differences in the lesioned spinal cords between the different recovery groups were found for N-acetyl-aspartate and choline. NAA/Cr was detected significantly (P<0.001, ANOVA) less in the group that did show permanent neurological deficits. To the contrary, choline was detected significantly (P<0.001, ANOVA) more in the group that did show permanent neurological deficits. Histologically the first group showed more apoptosis and necrosis than the second and third group.
CONCLUSIONS: MR spectroscopy (MRS) may be helpful for clinicians in improving the prognostic accuracy in cervical myelopathies since this method nicely reflects the extent and severity of spinal cord damage.

Entities:  

Keywords:  Subacute and chronic spinal cord compression; ex vivo 1H MR spectroscopy (MRS)

Year:  2017        PMID: 28744498      PMCID: PMC5506318          DOI: 10.21037/jss.2017.05.08

Source DB:  PubMed          Journal:  J Spine Surg        ISSN: 2414-4630


  25 in total

1.  Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100 beta.

Authors:  Gerhard Marquardt; Matthias Setzer; Volker Seifert
Journal:  Neurosurgery       Date:  2006-03       Impact factor: 4.654

2.  Diffusion tensor imaging predicts functional impairment in mild-to-moderate cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; John W Grinstead; Langston T Holly
Journal:  Spine J       Date:  2014-02-20       Impact factor: 4.166

3.  Metabolic Imaging Using Proton Magnetic Spectroscopy as a Predictor of Outcome After Surgery for Cervical Spondylotic Myelopathy.

Authors:  Langston T Holly; Benjamin M Ellingson; Noriko Salamon
Journal:  Clin Spine Surg       Date:  2017-06       Impact factor: 1.876

4.  Protein S-100b as serum marker for prediction of functional outcome in metastatic spinal cord compression.

Authors:  G Marquardt; M Setzer; V Seifert
Journal:  Acta Neurochir (Wien)       Date:  2004-03-22       Impact factor: 2.216

5.  Prognostic relevance of serial S100b and NSE serum measurements in patients with spinal intradural lesions.

Authors:  Gerhard Marquardt; Matthias Setzer; Andrea Szelenyi; Volker Seifert; Rüdiger Gerlach
Journal:  Neurol Res       Date:  2008-11-26       Impact factor: 2.448

6.  Significance of serial S100b and NSE serum measurements in surgically treated patients with spondylotic cervical myelopathy.

Authors:  G Marquardt; M Setzer; A Szelenyi; V Seifert; R Gerlach
Journal:  Acta Neurochir (Wien)       Date:  2009-06-05       Impact factor: 2.216

Review 7.  Advances in MR imaging for cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; Langston T Holly
Journal:  Eur Spine J       Date:  2013-08-06       Impact factor: 3.134

8.  Clinicopathological study of "snake-eye appearance" in compressive myelopathy of the cervical spinal cord.

Authors:  Junichi Mizuno; Hiroshi Nakagawa; Tatsushi Inoue; Yoshio Hashizume
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

9.  Reevaluation of the Pavlov ratio in patients with cervical myelopathy.

Authors:  Kyung-Soo Suk; Ki-Tack Kim; Jung-Hee Lee; Sang-Hun Lee; Jin-Soo Kim; Jin-Young Kim
Journal:  Clin Orthop Surg       Date:  2009-02-06

10.  Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells--a preclinical MR study in mice.

Authors:  Claudia Weidensteiner; Peter R Allegrini; Melanie Sticker-Jantscheff; Vincent Romanet; Stephane Ferretti; Paul M J McSheehy
Journal:  BMC Cancer       Date:  2014-02-14       Impact factor: 4.430

View more
  1 in total

1.  Metabolites of neuroinflammation relate to neuropathic pain after spinal cord injury.

Authors:  Dario Pfyffer; Patrik O Wyss; Eveline Huber; Armin Curt; Anke Henning; Patrick Freund
Journal:  Neurology       Date:  2020-06-26       Impact factor: 9.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.